Authors:
Stepensky, D
Friedman, M
Srour, W
Raz, I
Hoffman, A
Citation: D. Stepensky et al., Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation, J CONTR REL, 71(1), 2001, pp. 107-115
Authors:
Wainstein, J
Metzger, M
Wexler, ID
Cohen, J
Raz, I
Citation: J. Wainstein et al., The use of continuous insulin delivery systems in severely insulin-resistant patients, DIABET CARE, 24(7), 2001, pp. 1299-1299
Authors:
Raz, I
Elias, D
Avron, A
Tamir, M
Metzger, M
Cohen, IR
Citation: I. Raz et al., beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phaseII trial, LANCET, 358(9295), 2001, pp. 1749-1753
Authors:
Lewis, EJ
Hunsicker, LG
Clarke, WR
Berl, T
Pohl, MA
Lewis, JB
Ritz, E
Atkins, RC
Rohde, R
Raz, I
Citation: Ej. Lewis et al., Renoprotective effect of the angiotensin-receptor antagonist irbesartan inpatients with nephropathy due to type 2 diabetes, N ENG J MED, 345(12), 2001, pp. 851-860
Authors:
Keynan, S
Hirshberg, B
Levin-Iaina, N
Wexler, ID
Dahan, R
Reinhartz, E
Ovadia, H
Wollman, Y
Chernihovskey, T
Iaina, A
Raz, I
Citation: S. Keynan et al., Renal nitric oxide production during the early phase of experimental diabetes mellitus, KIDNEY INT, 58(2), 2000, pp. 740-747
Authors:
Shpichinetsky, V
Raz, I
Friedlander, Y
Goldschmidt, N
Wexler, ID
Ben-Yehuda, A
Friedman, G
Citation: V. Shpichinetsky et al., The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathyin type II diabetic patients, J NUTR, 130(10), 2000, pp. 2493-2497
Authors:
Abulafia-Lapid, R
Elias, D
Raz, I
Keren-Zur, Y
Atlan, H
Cohen, IR
Citation: R. Abulafia-lapid et al., T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides, J AUTOIMMUN, 12(2), 1999, pp. 121-129
Authors:
Datta, U
Wexler, ID
Kerr, DS
Raz, I
Patel, MS
Citation: U. Datta et al., Characterization of the regulatory region of the human testis-specific form of the pyruvate dehydrogenase alpha-subunit (PDHA-2) gene, BBA-GENE ST, 1447(2-3), 1999, pp. 236-243
Authors:
Sade, K
Schwartz, D
Wolman, Y
Schwartz, I
Chernichovski, T
Blum, M
Brazowski, E
Keynan, S
Raz, I
Blantz, RC
Iaina, A
Citation: K. Sade et al., Time course of lipopolysaccharide-induced nitric oxide synthase mRNA expression in rat glomeruli, J LA CL MED, 134(5), 1999, pp. 471-477
Authors:
Freier, S
Weiss, O
Eran, M
Flyvbjerg, A
Dahan, R
Nephesh, I
Safra, T
Shiloni, E
Raz, I
Citation: S. Freier et al., Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon, GUT, 44(5), 1999, pp. 704-708
Authors:
Lomnicky, Y
Friedman, M
Luria, MH
Raz, I
Hoffman, A
Citation: Y. Lomnicky et al., The effect of the mode of administration on the hypolipidaemic activity ofniacin: Continuous gastrointestinal administration of low-dose niacin improves lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats, J PHARM PHA, 50(11), 1998, pp. 1233-1239